We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis.
- Authors
Kötter, I; Zierhut, M; Eckstein, A K; Vonthein, R; Ness, T; Günaydin, I; Grimbacher, B; Blaschke, S; Meyer-Riemann, W; Peter, H H; Stübiger, N
- Abstract
Behçet's disease is a multisystem vasculitis of unknown origin. Standard treatment mainly comprises systemic immunosuppressive agents. Ocular involvement, mostly posterior uveitis with retinal vasculitis, leads to blindness in 20-50% of the involved eyes within 5 years. The efficacy of interferon alfa-2a was studied in patients with sight threatening posterior uveitis or retinal vasculitis.
- Publication
The British journal of ophthalmology, 2003, Vol 87, Issue 4, p423
- ISSN
0007-1161
- Publication type
Journal Article
- DOI
10.1136/bjo.87.4.423